https://t.co/YxnFgcnID2
Clinical trials of new drugs for Alzheimer disease.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2020 – Nov 2024Where it's discussed
-
News40 articles
-
X / Twitter12 posts
-
YouTube3 videos
-
Blogs3 articles
AI synopsis
What people are saying
The discussions mainly consist of repetitive mentions of research limitations or skepticism, such as references to the 'limited effects' and frustration with current treatments, which reflect a generally dismissive attitude. The tone and concise language contribute to a perception of low engagement and impact, as participants are more passively sharing echoes rather than actively analyzing or supporting the research.
Most discussions seem skeptical or dismissive of the publication's findings, with words and tones indicating disagreement or disappointment.
Participants show minimal interest, as most posts lack detailed analysis or curiosity, focusing instead on general comments.
Posts appear shallow, often repeating similar phrases or sharing links without deep discussion or critique.
The overall tone suggests the publication's influence on these discussions is limited, with little indication of significant change or contemplation.
Abstract in brief
- Alzheimer's disease (AD) accounts for 60-70% of dementia cases, and developing effective therapies is urgent due to its increasing prevalence.
- Current treatments only temporarily relieve symptoms without stopping or reversing the disease, and many amyloid-targeting trials have failed, suggesting the amyloid hypothesis might not be fully correct.
- Ongoing research involves diverse approaches such as targeting amyloid and tau proteins, neuroprotection, cognitive enhancement, and managing behavioral symptoms, with future trials focusing on understanding disease mechanisms and exploring new strategies beyond amyloid clearing.]
Top posts
Most liked on X and Bluesky阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/Zde6YZ0lka via @YouTube
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/6rf4Du6AIX via @YouTube
Clinical trials of new drugs for Alzheimer disease | Journal of Biomedical Science | Full Text https://t.co/wPFhNb7TQK
https://t.co/tRPsHjo2nv
阿茲海默症的研究新突破 https://t.co/HmbDQX3z2F
All mentions
Advances in Alzheimer's Disease Research and Drug Development Strategies
This video discusses current research and clinical trials for Alzheimer's disease, focusing on drug development challenges, diverse approaches like targeting amyloid and tau proteins, and exploring new treatment…
Advances in Alzheimer's Drug Trials Focus on Neuroprotection and Disease Mechanisms
Alzheimer's disease accounts for 60-70% of dementia cases; current treatments are symptomatic. Ongoing clinical trials explore diverse approaches, including targeting amyloid and tau proteins, neuroprotection, and new…
Advances in Alzheimer's Drug Trials and Future Therapies
Alzheimer's disease accounts for 60-70% of dementia cases. Current treatments only temporarily relieve symptoms, and many amyloid-targeting trials have failed, prompting exploration of diversified approaches like…
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/Na3YPxyg4t 15:10 PanSci 泛科學 87.8萬位訂閱者
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/Zde6YZ0lka via @YouTube
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/6rf4Du6AIX via @YouTube
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/lwtRqo6L86 來自 @YouTube
https://t.co/YxnFgcnID2
https://t.co/tRPsHjo2nv
阿茲海默症的研究新突破 https://t.co/HmbDQX3z2F
阿茲海默症靠吃藥效果有限?關鍵基因終於找到了!2022年爆發大型研究醜聞,類澱粉蛋白假說還站得住腳嗎? https://t.co/WDpMUwNny4 來自 @YouTube
奔跑吧!大腦 https://t.co/S1kRKYX3o2 來自 @YouTube
Une étude comparative de traitements contre #Maladie #Alzheimer. https://t.co/AH6zmYwlg8
Clinical trials of new drugs for Alzheimer disease | Journal of Biomedical Science | Full Text https://t.co/wPFhNb7TQK
Clinical trials of new drugs for Alzheimer disease. J Biomed Sci #Alzheimers https://t.co/tXpfKV3VWN